Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 7, 2014, Pages 981-988

  Chung, Paul H ^a   Krabbe, Laura Maria ^a,b   Darwish, Oussama M ^a   Westerman, Mary E ^a   Bagrodia, Aditya ^a   Gayed, Bishoy A ^a   Haddad, Ahmed Q ^a   Kapur, Payal ^a   Sagalowsky, Arthur I ^a   Lotan, Yair ^a   Margulis, Vitaly ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Chemotherapy; Hydronephrosis; Nephroureterectomy; Outcome; Upper tract urothelial carcinoma

Indexed keywords

MITOMYCIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; HYDRONEPHROSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY; COMPLICATION; KAPLAN MEIER METHOD; KIDNEY PELVIS; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; URETER TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; HYDRONEPHROSIS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; URETERAL NEOPLASMS;

EID: 84922397482     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.02.018     Document Type: Article

References (24)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Roupret M., Babjuk M., Comperat E., et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 2013, 63:1059-1071.
3. Lughezzani G., Burger M., Margulis V., et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 2012, 62:100-114.
4. Lane B.R., Smith A.K., Larson B.T., et al. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 2010, 116:2967-2973.
5. Audenet F., Yates D.R., Cussenot O., Roupret M. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). Urol Oncol 2013, 31:407-413.
6. Margulis V., Youssef R.F., Karakiewicz P.I., et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 2010, 184:453-458.
7. Stimson C.J., Cookson M.S., Barocas D.A., et al. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J Urol 2010, 183:1732-1737.
8. Ng C.K., Shariat S.F., Lucas S.M., et al. Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?. Urol Oncol 2011, 29:27-32.
9. Brien J.C., Shariat S.F., Herman M.P., et al. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 2010, 184:69-73.
10. Messer J.C., Terrell J.D., Herman M.P., et al. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urol Oncol 2013, 31:904-908.
11. Zhang X., Zhu Z., Zhong S., Xu T., Shen Z. Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria. World J Urol 2013, 31:155-160.
12. Cho K.S., Hong S.J., Cho N.H., Choi Y.D. Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma. Urology 2007, 70:662-666.
13. Bozzini G., Nison L., Colin P., et al. Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort. World J Urol 2013, 31:83-91.
14. Favaretto R.L., Shariat S.F., Savage C., et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 2012, 109:77-82.
15. Ito Y., Kikuchi E., Tanaka N., et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol 2011, 185:1621-1626.
16. O'Brien T., Ray E., Singh R., Coker B., Beard R. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 2011, 60:703-710. British Association of Urological Surgeons Section of Oncology.
17. Miyamoto H., Miller J.S., Fajardo D.A., Lee T.K., Netto G.J., Epstein J.I. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system. Pathol Int 2010, 60:1-8.
18. Cummings K.B. Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract. Urol Clin North Am 1980, 7:569-578.
19. Matin S.F., Margulis V., Kamat A., et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 2010, 116:3127-3134.
20. Youssef R.F., Shariat S.F., Lotan Y., et al. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU Int 2011, 108:1286-1291.
21. Kaag M.G., O'Malley R.L., O'Malley P., et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 2010, 58:581-587.
22. Scolieri M.J., Paik M.L., Brown S.L., Resnick M.I. Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 2000, 56:930-934.
23. Guarnizo E., Pavlovich C.P., Seiba M., Carlson D.L., Vaughan E.D., Sosa R.E. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 2000, 163:52-55.
24. Chang T.C., Changchien C.C., Tseng C.W., et al. Retrograde lymphatic spread: a likely route for metastatic ovarian cancers of gastrointestinal origin. Gynecol Oncol 1997, 66:372-377.